• 3552 Citations
  • 26 h-Index
20082019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Carmen Criscitiello is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumor-Infiltrating Lymphocytes Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Estrogen Receptors Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 3552 Citations
  • 26 h-Index
  • 77 Article
  • 8 Review article
  • 2 Chapter
Open Access
Triple Negative Breast Neoplasms
Medical Oncology
Platinum
Drug Therapy
Febrile Neutropenia
5 Citations (Scopus)

A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer

Criscitiello, C., Bayar, M. A., Curigliano, G., Symmans, F. W., Desmedt, C., Bonnefoi, H., Sinn, B., Pruneri, G., Vicier, C., Pierga, J. Y., Denkert, C., Loibl, S., Sotiriou, C., Michiels, S. & André, F., Jan 1 2018, In : Annals of Oncology. 29, 1, p. 162-169 8 p., mdx691.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
Tumor-Infiltrating Lymphocytes
Drug Therapy
Genes
Survival
2 Citations (Scopus)

Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer

Duso, B. A., Trapani, D., Viale, G., Criscitiello, C., D’Amico, P., Belli, C., Mazzarella, L., Locatelli, M., Minchella, I. & Curigliano, G., Feb 11 2018, In : Expert Opinion on Pharmacotherapy. 19, 3, p. 299-305 7 p.

Research output: Contribution to journalArticle

Hormones
Breast Neoplasms
Therapeutics
Expert Testimony
Cause of Death
6 Citations (Scopus)

Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis

Criscitiello, C., Golshan, M., Barry, W. T., Viale, G., Wong, S., Santangelo, M. & Curigliano, G., Jul 1 2018, In : European Journal of Cancer. 97, p. 1-6 6 p.

Research output: Contribution to journalArticle

Segmental Mastectomy
Meta-Analysis
Breast Neoplasms
Drug Therapy
Neoadjuvant Therapy
12 Citations (Scopus)

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

Malorni, L., Curigliano, G., Minisini, A. M., Cinieri, S., Tondini, C. A., D'Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I. & 2 others, Biganzoli, L. & Di Leo, A., Jan 1 2018, In : Annals of Oncology. 29, 8, p. 1748-1754 7 p.

Research output: Contribution to journalArticle

Estrogen Receptors
Disease Progression
Breast Neoplasms
Confidence Intervals
Disease-Free Survival